TRP — Tissue Repair Income Statement
0.000.00%
- AU$17.37m
- -AU$1.89m
- AU$0.00m
- 57
- 20
- 74
- 51
Annual income statement for Tissue Repair, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.003 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.557 | 0.501 | 0.553 | 5.28 | 4.77 |
Operating Profit | -0.557 | -0.501 | -0.553 | -5.28 | -4.77 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.555 | -0.501 | -0.915 | -6.84 | -4.17 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.357 | -0.352 | -0.915 | -6.84 | -4.17 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.357 | -0.352 | -0.915 | -6.84 | -4.17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.357 | -0.352 | -0.915 | -6.84 | -4.17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.006 | -0.006 | -0.052 | -0.113 | -0.069 |